Value through Innovation27 July 2016

What is a lay summary?

To view this video in other translations click on the language below:
Chinese (simplified)
Chinese (traditional)
French
German
Italian
Japanese
Portuguese (Brazilian)
Spanish

Clinical Study Results

  • BI 224436 - Healthy
    Clinical Study Number 1277.1
    Study Indication Healthy
    Product BI 224436
    Generic Name BI 224436
    Lab Code
    Clinical Phase I
    Study Title

    Safety and pharmacokinetics of single rising oral doses of BI 224436 ZW at 6.2 mg, 12.5 mg, 25 mg, 50 mg, 100 mg, 200 mg, 400 mg, 600 mg, 900 mg and1200 mg dose levels in healthy male volunteers (randomized, double-blind,placebo-controlled within dose groups). 

    Study Document
    Trial synopsis 1277.1_CO english